Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

CK Appel, S Gallego-Pedersen, L Andersen, S Blancheflor Kristensen, Ming Ding, S Falk, M Sayilekshmy, C Gabel-Jensen, AM Heegaard

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

85 Downloads (Pure)

Abstract

The Acknowledgements section in this Article is incomplete. “The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond.” should read: “The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 642720.”

OriginalsprogEngelsk
Artikelnummer7399
TidsskriftScientific Reports
Vol/bind9
Antal sider1
ISSN2045-2322
DOI
StatusUdgivet - 9. maj 2019

Fingeraftryk

Dyk ned i forskningsemnerne om 'Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.'. Sammen danner de et unikt fingeraftryk.

Citationsformater